Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Reproducible And Interpretable Machine Learning-based Radiomic Analysis For Overall Survival Prediction In Glioblastoma Multiforme.
  1. Home
  3. Reproducible And Interpretable Machine Learning-based Radiomic Analysis For Overall Survival Prediction In Glioblastoma Multiforme.

Related Experiment Video

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.7K

Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in

Abdulkerim Duman1, Xianfang Sun2, Solly Thomas3

  • 1School of Engineering, Cardiff University, Cardiff CF24 3AA, UK.

Cancers
|October 16, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

A new MRI radiomic model predicts glioblastoma survival. This clinical-radiomic model effectively stratifies patients into low and high-risk groups for overall survival (OS).

Keywords:
clinical applicationsglioblastoma multiformemachine learningmagnetic resonance imaging (MRI)radiomics

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.6K
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
08:02

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

16.4K

Related Experiment Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.7K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.6K
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
08:02

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

16.4K

Area of Science:

  • Radiomics and Medical Imaging
  • Oncology
  • Machine Learning in Healthcare

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis.
  • Accurate prediction of overall survival (OS) is crucial for treatment planning and patient management.
  • Existing prognostic models often lack precision, necessitating novel predictive tools.

Purpose of the Study:

  • To develop and validate an MRI-based radiomic model for predicting OS in GBM patients.
  • To integrate radiomic features with clinical variables for enhanced prognostic accuracy.
  • To stratify GBM patients into distinct risk groups based on predicted survival.

Main Methods:

  • Retrospective analysis of pre-treatment MRI scans from 289 GBM patients across multiple institutions.
  • Extraction and robustness analysis of 660 radiomic features (RFs) from tumor volumes.
  • Development of a clinical-radiomic model using cross-validation, incorporating age and two robust RFs from T2-FLAIR imaging.

    • Main Results:

    • The final model achieved a C-Index of 0.69 (95% CI: 0.62-0.75), demonstrating moderately good discriminatory performance.
    • Significant patient stratification into low and high-risk groups was achieved (p = 7 × 10^-5) on the validation cohort.
    • The model achieved the highest integrated area under the curve (iAUC) at 11 months (0.81) compared to existing literature.

    Conclusions:

    • A validated clinical-radiomic model effectively stratifies GBM patients based on OS.
    • The model utilizes interpretable features, including primary gross tumor volume (GTV) and T2-FLAIR radiomic features.
    • Future research will explore deep learning-based features for improved OS prediction in GBM.